The Role of Quality Management in Modern CRDMOs
BIOSECURE Act: Companies turn to US manufacturers
Indian CDMO Companies Must Level Up for Opportunity from US Biosecure Act
How Syngene Is Revving Up Capabilities In ADCs, PROTACs
Bharat Eyes Global Biomanufacturing Dominance: Boosting Innovation, Collaboration & Entrepreneurship with BioE3 Policy
Forging Ahead in Formulation
Syngene expands supply chain with China-free options
US Biosecure Act: Impact on Indian pharma companies
Evolving trends for Big Pharma to benefit Syngene, says CFO Sibaji Biswas
Pharma & biotech industry propels ESG implementation with concerns over climate change & global supply disruptions
